12 December 2018: vol 19 no 18: Final issue of 2018
12 December 2018. Related: Editorial.
2018
Glasgow HIV Congress (2018) – second reports
12 December 2018. Related: Conference reports.
Hepatitis C is an independent risk factor for preterm delivery in HIV positive women: data from a Warsaw cohort
12 December 2018. Related: Conference reports, Pregnancy.
Vertical transmission remains very low in UK and Ireland: update from the National Study of HIV in Pregnancy and Childhood
12 December 2018. Related: Conference reports, Pregnancy.
3rd HIV Research for Prevention Conference (R4P2018) – second reports
12 December 2018. Related: Conference reports, HIV prevention and transmission.
3D printing technology has potential to individualise production of vaginal rings
12 December 2018. Related: Conference reports, HIV prevention and transmission.
22nd International AIDS Conference (AIDS 2018) – final report
12 December 2018. Related: Conference reports.
No significant decrease in raltegravir free fraction during pregnancy
12 December 2018. Related: Conference reports, Paediatric care, PK and drug interactions.
Updates from Liverpool University drug interactions website
12 December 2018. Related: PK and drug interactions.
FDA approves generic TDF/3TC for use in the US
12 December 2018. Related: Antiretrovirals.
New community recommendations for HIV cure studies that include a treatment interruption
12 December 2018. Related: Cure-related research.
IAS condemns Tanzania’s anti-gay initiatives
12 December 2018. Related: Other news.
Essential viewing: Live Growing Up – CHIVA 2018 video…
12 December 2018. Related: Other news, On the web.
12 December 2018: vol 19 no 18
12 December 2018. Related: PDFs.
Doravirine (Pifeltro) and doravirine/TDF/3TC FDC (Delstrigo) approved in Europe
1 December 2018. Related: Antiretrovirals.
13 November 2018: vol 19 no 17: HIVR4P and Glasgow conferences: first reports
13 November 2018. Related: Editorial.
Glasgow HIV Congress (2018)
13 November 2018. Related: Conference reports.
No additional neural tube defects with preconception dolutegravir: data from three birth outcome cohorts
13 November 2018. Related: Conference reports, Pregnancy, Paediatric care.
Insufficient data on risk of neural tube defects with exposure to elvitegravir or bictegravir exposure during preconception or first trimester
13 November 2018. Related: Conference reports, Pregnancy.
Viral dynamics of dolutegravir-based dual versus triple ART
13 November 2018. Related: Conference reports, Antiretrovirals.
Ibalizumab: 48-week phase 3 results in 27 participants with MDR HIV
13 November 2018. Related: Conference reports, Antiretrovirals.
Fostemsavir: 48-week phase 3 results from BRIGHTE study
13 November 2018. Related: Conference reports, Antiretrovirals.
Dolutegravir non-inferior to low dose efavirenz in real-life African study conducted in Cameroon
13 November 2018. Related: Conference reports, Antiretrovirals, Treatment strategies.
3rd HIV Research for Prevention Conference (R4P2018)
13 November 2018. Related: Conference reports, HIV prevention and transmission.
How to evaluate PrEP and vaccines: urgency for next generation compounds
13 November 2018. Related: Conference reports, HIV prevention and transmission, Cure-related research, Research studies.
Dual bNAb maintains viral suppression for median 21 weeks off-ART
13 November 2018. Related: Conference reports, Antiretrovirals, Treatment strategies.
Cabotegravir levels can be detected several years: PK tail to be covered by oral PrEP
13 November 2018. Related: Conference reports, Antiretrovirals.
3D imaging show HIV infection might establish within hours
13 November 2018. Related: Conference reports, HIV prevention and transmission.
bNAbs for HIV prevention: extended-release VRC01, AMP study, 10E8 safety signal and pan-clade challenges
13 November 2018. Related: Conference reports, PK and drug interactions, HIV prevention and transmission.
Why U=U does not cover breastfeeding
13 November 2018. Related: Conference reports, Paediatric care.
FDA updates rilpivirine label for use during pregnancy
13 November 2018. Related: Antiretrovirals.
EACS guidelines – version 9.1 update (2018)
13 November 2018. Related: Guidelines.
Activists demand $1 a day access to bedaquiline for MDR TB
13 November 2018. Related: Treatment access, TB coinfection.
Cannabis-based products for medicinal use: Guidance to clinicians
13 November 2018. Related: Side effects, Other news.
13 November 2018: vol 19 no 17
13 November 2018. Related: PDFs.
19 October 2018: vol 19 no 16: BHIVA and Ageing Conferences, PrEP guidelines
19 October 2018. Related: Editorial.
BHIVA Autumn Conference 2018
19 October 2018. Related: Conference reports.
Second case of potential HIV eradication
19 October 2018. Related: Conference reports, Cure-related research.
New UK PrEP guidelines 2018
19 October 2018. Related: Conference reports, HIV prevention and transmission.
Other selected talks at BHIVA Autumn 2018
19 October 2018. Related: Conference reports.
9th International Workshop on HIV and Ageing
19 October 2018. Related: Conference reports, Lipodystrophy and metabolic complications, Coinfections and complications.
Detectable viral load quadruples odds of recurrent falls in older men with HIV
19 October 2018. Related: Conference reports, Coinfections and complications.
Dolutegravir/lamividune FDC submitted to EMA and FDA
19 October 2018. Related: Antiretrovirals.
More than 40% of HIV group has hepatic steatosis, regardless of age
19 October 2018. Related: Conference reports, Coinfections and complications.
Associations of loneliness with cognitive function and quality of life (QoL) among older adults living with HIV – 18% lonely quite often
19 October 2018. Related: Conference reports, Coinfections and complications.
Physical function worse in older women than men with HIV, despite better CD4 recovery
19 October 2018. Related: Conference reports, Coinfections and complications.
Post-AIDS 2018 updates on HIV cure research
19 October 2018. Related: Cure-related research.
UK government funding cuts leave sexual health and HIV care at breaking point
19 October 2018. Related: Treatment access.
Brazilian court suspends patent on hepatitis C medicine sofosbuvir
19 October 2018. Related: Treatment access, Hepatitis coinfection.
UK PrEP guidelines now online (2018)
19 October 2018. Related: Guidelines, HIV prevention and transmission.
HIV positive mother is living donor to negative child: HIV is considered an acceptable outcome of liver transplant
19 October 2018. Related: Other news.
LGBT HIV activist Zak Kostopoulos murdered in Athens: campaign calls for justice
19 October 2018. Related: Other news.
19 October 2018: vol 19 no 16
19 October 2018. Related: PDFs.
19 September 2018: vol 19 no 15
19 September 2018. Related: PDFs.
19 September 2018: vol 19 no 15: UK diagnoses, U=U resources, generic PrEP
19 September 2018. Related: Editorial.
U=U resources for UK clinics: free posters, postcards and factsheets
19 September 2018. Related: Editorial, Supplements.
HIV diagnoses in UK drop for third year: among all ages, risk groups, and ethnicities and across most UK regions
19 September 2018. Related: Special reports, HIV prevention and transmission.
22nd International AIDS Conference (AIDS 2018) – third reports
19 September 2018. Related: Conference reports.
Dolutegravir twice daily is effective and tolerable with rifampicin: 48 week results from the INSPIRING study
19 September 2018. Related: Conference reports, TB coinfection.
TAF exposures during pregnancy and postpartum appear adequate but more data are needed
19 September 2018. Related: Conference reports, Pregnancy.
High rate of unintended pregnancy among HIV positive African women on ART
19 September 2018. Related: Conference reports, Women's health, Pregnancy.
English court finds in favour of access to generic TDF/FTC
19 September 2018. Related: Antiretrovirals, HIV prevention and transmission, Other news.
FDA approves doravirine (Pifeltro) and new FDC with TDF/3TC (Delstrigo) in the US
19 September 2018. Related: Antiretrovirals.
FDA update labels for dolutegravir and dolutegravir-based FDCs to reflect potential risk of neural tube defects
19 September 2018. Related: Antiretrovirals.
Alcohol and HIV: new issue of RITA
19 September 2018. Related: On the web.